3rdPartyFeeds

SHAREHOLDER ALERT: CAN VMW GOSS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / April 26, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss ... Read More...

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="NEW YORK, NY / ACCESSWIRE / April 26, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.” data-reactid=”12″>NEW YORK, NY / ACCESSWIRE / April 26, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Canaan Inc. (CAN)” data-reactid=”13″>Canaan Inc. (CAN)

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/canaan-inc-loss-submission-form?prid=6185&amp;wire=1
Lead Plaintiff Deadline: May 4, 2020
Class Period: publicly traded securities of Canaan, including its American Depository Shares pursuant and/or traceable to the Company’s registration statement and related prospectus issued in connection with the Company’s November 20, 2019 initial public offering.” data-reactid=”14″>If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/canaan-inc-loss-submission-form?prid=6185&wire=1
Lead Plaintiff Deadline: May 4, 2020
Class Period: publicly traded securities of Canaan, including its American Depository Shares pursuant and/or traceable to the Company’s registration statement and related prospectus issued in connection with the Company’s November 20, 2019 initial public offering.

Allegations against CAN include that: (1) the purported “strategic cooperation” was actually a transaction with a related party; (2) the company’s financial health was worse than what was actually reported; (3) the company had recently removed numerous distributors from its website just prior to the initial public offering, many of which were small or suspicious businesses; and (4) several of the Company’s largest Chinese clients in prior years were clients who were not in the Bitcoin mining industry and, thus, would likely not be repeat customers.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="VMware, Inc. (VMW)” data-reactid=”16″>VMware, Inc. (VMW)

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/vmware-inc-loss-submission-form?prid=6185&amp;wire=1
Lead Plaintiff Deadline: June 1, 2020
Class Period: March 30, 2019 to February 27, 2020″ data-reactid=”17″>If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/vmware-inc-loss-submission-form?prid=6185&wire=1
Lead Plaintiff Deadline: June 1, 2020
Class Period: March 30, 2019 to February 27, 2020

Allegations against VMW include that: (i) VMware’s reporting with respect to its backlog of unfilled orders was not in compliance with all relevant accounting and disclosure requirements; (ii) the foregoing subjected the Company to a foreseeable risk of heightened regulatory scrutiny and/or investigation; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Gossamer Bio, Inc. (GOSS)” data-reactid=”19″>Gossamer Bio, Inc. (GOSS)

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/gossamer-bio-inc-loss-submission-form?prid=6185&amp;wire=1
Lead Plaintiff Deadline: June 2, 2020
Class Period: common stock between February 8, 2019 and December 13, 2019 and/or who acquired Gossamer shares pursuant or traceable to Gossamer’s documents issued in connection with its February 8, 2019 initial public offering.” data-reactid=”20″>If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/gossamer-bio-inc-loss-submission-form?prid=6185&wire=1
Lead Plaintiff Deadline: June 2, 2020
Class Period: common stock between February 8, 2019 and December 13, 2019 and/or who acquired Gossamer shares pursuant or traceable to Gossamer’s documents issued in connection with its February 8, 2019 initial public offering.

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose: (1) the reasons for Gossamer’s GB001 trial failures; (2) the purported clinical validation of Novartis’ oral DP2 antagonist; and (3) that, as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.” data-reactid=”22″>To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]” data-reactid=”24″>CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="SOURCE: The Law Offices of Vincent Wong” data-reactid=”25″>SOURCE: The Law Offices of Vincent Wong

View source version on accesswire.com:
https://www.accesswire.com/587046/SHAREHOLDER-ALERT-CAN-VMW-GOSS-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines

Read More

Add Comment

Click here to post a comment